1. Home
  2. Jethmalani quits as Kejriwal's counsel, seeks Rs 2 crore fee

Jethmalani quits as Kejriwal's counsel, seeks Rs 2 crore fee

TNN
July 26, 2017

New Delhi, Jul 26: Ram Jethmalani has quit as chief minister Arvind Kejriwal's counsel in the civil and criminal defamation cases filed by Union finance minister Arun Jaitley against the CM.jethmalani

Following Kejriwal's denial of having instructed the lawyer to use derogatory language against Jaitley during court proceedings on May 17, the lawyer has written a letter to the CM, accusing him of using even more offensive language against Jaitley during private discussions on the case.

Jethmalani has asked Kejriwal to settle his legal fees amounting to more than Rs 2 cro5re. The lawyer used an offensive word, amounting to accusing Jaitley of being a criminal, during proceedings of the Rs 10-crore defamation case against Kejriwal and five other AAP leaders.

Jaitley asked Jethmalani if the word was spoken on his client's instruction. The lawyer replied in the affirmative and Jaitley filed another Rs 10-crore defamation suit against the CM.

Stung by the fresh defamation suit, Kejriwal filed an affidavit in Delhi high court and wrote a letter to Jethmalani saying he had not given any instructions for use of the derogatory word.

In his affidavit, Kejriwal said it was " inconceivable that he would even think of instructing the senior counsel to use such objectionable words". "Neither the defendant (Kejriwal) nor the counsel (Anupam Srivastava) briefing the senior counsel (Jethmalani) gave instructions to the senior counsel to use the objectionable words on May 17, 2017," Kejriwal said in the affidavit.

In response, after conveying his decision to quit as the CM's advocate, Jethmalani also told the CM to settle his legal fee, which, by a conservative estimate, would be over Rs 2 crore. The Delhi government had, this February, cleared a payment of Rs 3.5 crore to Jethmalani, which included Rs 1 crore as retainer and Rs 22 lakh as fee for each appearance in court.

However, the chief minister's office refused to comment on the matter, saying they "have no intimation on Jethmalani withdrawing from the case so far".

Jethmalani said, "Kejriwal has written a letter to me. I have replied to that. I am not going to divulge the details of either of the letters. You ask Kejriwal to make public both the letters. I have promised him not to make it public."

Sources said, in his letter, Jethmalani reminded Kejriwal about many conferences they had at the lawyer's residence and during which he had informed the CM about how PM Narendra Modi, impressed by his relentless fight against black money, had asked him to join BJP in 2010.

The letter also said the CM had shared the lawyer's anguish about BJP doing nothing to keep its election-eve promise to get back black money and deposit Rs 15 lakh in every Indian's bank account and how Jethmalani held Modi and Jaitley responsible for this.

During such conversations, Jethmalani alleged in his letter, Kejriwal had used even more objectionable words against Jaitley. The alleged use of derogatory words by Kejriwal during the conference appeared to have made Jethmalani repeat them during the May 17 proceedings before the HC registrar in the first defamation suit.

Jaitley had filed an application for expediting the recording of evidence in an orderly and fair manner in the first Rs 10-crore defamation suit against Kejriwal and the five AAP leaders for making allegations of corruption against him by them.

Comments

Rajarama Shetty
 - 
Thursday, 27 Jul 2017

Mr. Ramanath Rai is able & experienced .six time MLA..!! MOST SENIOR .dedicated CONGRESS MAN for more than 40 years?

Are there better candidates than him?

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 30,2020

New Delhi, May 30: India witnessed the highest ever spike of 7,964 coronavirus positive cases in the last 24 hours, taking the total number of COVID-19 cases in the country to 1,73,763, according to the Union Ministry of Health and Family Welfare.

With as many as 265 deaths reported in the last 24 hours, the death toll due to the virus now stands at 4,971.

Out of the total number of coronavirus cases, 86,422 are active and 82,370 have been cured/discharged/migrated.

Among the states, Maharashtra remains the worst-affected with 62,228 COVID-19 cases, followed by Tamil Nadu (20,246), Delhi (17,386) and Gujarat (15,934).

The fourth phase of the nationwide lockdown imposed as a precautionary measure to contain the spread of COVID-19 is slated to end on Sunday.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 13,2020

New Delhi, Feb 13: Arvind Kejriwal wrote to Delhi Lieutenant Governor Anil Baijal on Wednesday, staking claim to form the government in the national capital, sources said, while hinting that the AAP might not invite senior leaders and chief ministers of other parties for the oath-taking ceremony.

The sources said it was the formal process by the AAP chief, who was elected as the legislature party leader earlier in the day, to stake claim for forming the new government.

Kejriwal, who returned to power in Delhi with a stunning poll victory on Tuesday, will take oath as chief minister for the third consecutive time on February 16.

While the oath-taking ceremony will be open to the public, the Aam Aadmi Party (AAP) was considering not inviting leaders and chief ministers of other parties as it did not wish to be seen as a "confrontationist" against the BJP-led Centre, the sources said.

They, however, added that the party was yet to take a decision on it.

The AAP has planned mobilisation of people for the mega event and all the newly-elected MLAs of the party have been asked to ensure huge participation from their constituencies.

"I request the people of Delhi to attend the oath-taking ceremony of the chief minister at the Ramlila Maidan in large numbers," senior AAP leader Manish Sisodia told reporters, adding that the ceremony will start at 10 am.

The AAP won 62 seats in the 70-member Delhi Assembly, while the Bharatiya Janata Party (BJP) bagged the remaining eight seats. The Congress drew a blank for the second consecutive time in the Delhi polls.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.